Heimdall Insights

Global Human Combination Vaccines Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Human Combination Vaccines Market was valued at $12.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.8% CAGR, to an estimated market size of $18.6 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global human combination vaccines market comprises multi-antigen formulations that integrate protection against several infectious diseases into a single injection. This scope includes pediatric, adolescent, and adult vaccines designed to simplify immunization schedules, improve patient compliance, and reduce healthcare logistics costs, while excluding monovalent vaccines and COVID-19 specific formulations unless part of a broader respiratory combination.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Human Combination Vaccines Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Conjugate & Next-Gen Vaccines